Location of tumor affects local and distant immune cell type and number

Tumors comprise heterogeneous populations of cells, including immune infiltrates that polarize during growth and metastasis. Our preclinical studies on breast cancer (BCa) identified functional differences in myeloid‐derived suppressor cells based on tumor microenvironment (TME), prompting variations in host immune response to tumor growth, and dissemination based on tissue type.

• Publication year

  2017

• Venue

  Immunity, Inflammation and Disease

• Publication date

  2017-02-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/iid3.144PMID 28250928PMCID 5322166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adoptive immunotherapy against ovarian cancer

  2016cited by this paper
• Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer

  2015cited by this paper
• Myeloid-derived cells are key targets of tumor immunotherapy

  2014cited by this paper
• Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.

  2014cited by this paper
• Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment

  2014cited by this paper
• Chronic Inflammation and Cytokines in the Tumor Microenvironment

  2014cited by this paper
• Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other viruses.

  2014cited by this paper
• Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.

  2014cited by this paper
• Regulation of Tumor Growth and Metastasis: The Role of Tumor Microenvironment

  2014cited by this paper
• Microenvironmental regulation of tumor progression and metastasis

  2013cited by this paper
• Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.

  2013cited by this paper
• Tumor-Associated Macrophages as a Paradigm of Macrophage Plasticity, Diversity, and Polarization: Lessons and Open Questions

  2013cited by this paper
• Suppression, subversion and escape: the role of regulatory T cells in cancer progression

  2013cited by this paper
• The metastasis-promoting roles of tumor-associated immune cells

  2013cited by this paper
• Innate and adaptive immune cells in the tumor microenvironment

  2013cited by this paper
• Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.

  2012cited by this paper
• Combining immunotherapy and targeted therapies in cancer treatment

  2012cited by this paper
• Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes

  2012cited by this paper
• The pro‐metastatic role of bone marrow‐derived cells: a focus on MSCs and regulatory T cells

  2012cited by this paper
• Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells

  2012cited by this paper
• Depletion of Plasmacytoid Dendritic Cells Inhibits Tumor Growth and Prevents Bone Metastasis of Breast Cancer Cells

  2012cited by this paper
• CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.

  2011cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• Macrophage diversity enhances tumor progression and metastasis.

  2010cited by this paper
• Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species

  2010cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model

  2009cited by this paper
• Regulatory T cells: how do they suppress immune responses?

  2009cited by this paper
• Immunosuppression induced by immature dendritic cells is mediated by TGF-β/IL-10 double-positive CD4+ regulatory T cells

  2007cited by this paper
• Tolerization of Tumor-Specific T Cells Despite Efficient Initial Priming in a Primary Murine Model of Prostate Cancer1

  2007cited by this paper
• B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

  2006cited by this paper
• Activated CD4+CD25+ T cells selectively kill B lymphocytes.

  2006cited by this paper
• Distinct role of macrophages in different tumor microenvironments.

  2006cited by this paper
• Cytotoxic T lymphocyte antigen‐4‐dependent down‐modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T‐cell‐mediated suppression

  2006cited by this paper
• Molecular markers of breast cancer metastasis

  2005cited by this paper
• Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells.

  2005cited by this paper
• Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.

  2005cited by this paper
• Breast cancer metastasis: markers and models

  2005cited by this paper
• CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte–macrophage colony-stimulating factor-dependent fashion

  2003cited by this paper
• Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

  2002cited by this paper
• CTLA-4–Ig regulates tryptophan catabolism in vivo

  2002cited by this paper
• TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.

  1999cited by this paper
• Cytokine regulation of angiogenesis in breast cancer: the role of tumor‐associated macrophages

  1995cited by this paper

• Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer

  2024cites this paper
• m5C regulator‐mediated methylation modification patterns and tumor microenvironment infiltration characteristics in acute myeloid leukemia

  2024cites this paper
• Unfavorable tumor responses to immunotherapy in the liver: Lessons learned from clinical and preclinical studies

  2023cites this paper
• Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer

  2023cites this paper
• Co-inhibitor expression on tumor infiltrating and splenic lymphocytes after dual checkpoint inhibition in a microsatellite stable model of colorectal cancer

  2021cites this paper
• Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways

  2021cites this paper
• Tumor models to assess immune response and tumor-microbiome interactions in colorectal cancer.

  2021cites this paper
• B19-VLPs as an effective delivery system for tumour antigens to induce humoral and cellular immune responses against triple negative breast cancer.

  2021cites this paper
• Tissue‐specific tumor microenvironments influence responses to immunotherapies

  2019cites this paper
• Suppressing immunotherapy by organ-specific tumor microenvironments: what is in the brain?

  2019cites this paper
• Nanofluidic drug‐eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer

  2018cites this paper
• ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response

  2018cites this paper
• Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses

  2018cites this paper
• Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations

  2018cites this paper
• Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers.

  2018cites this paper